79 related articles for article (PubMed ID: 18978097)
1. Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial.
Sawaya GF; Chirenje MZ; Magure MT; Tuveson JL; Ma Y; Shiboski SC; Da Costa MM; Palefsky JM; Moscicki AB; Mutasa RM; Chipato T; Smith-McCune KK
Obstet Gynecol; 2008 Nov; 112(5):990-7. PubMed ID: 18978097
[TBL] [Abstract][Full Text] [Related]
2. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.
Padian NS; van der Straten A; Ramjee G; Chipato T; de Bruyn G; Blanchard K; Shiboski S; Montgomery ET; Fancher H; Cheng H; Rosenblum M; van der Laan M; Jewell N; McIntyre J;
Lancet; 2007 Jul; 370(9583):251-261. PubMed ID: 17631387
[TBL] [Abstract][Full Text] [Related]
3. Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections.
Smith-McCune KK; Tuveson JL; Rubin MM; Da Costa MM; Darragh TM; Shiboski SC; Van Der Pol B; Moscicki AB; Palefsky JM; Sawaya GF
J Low Genit Tract Dis; 2006 Oct; 10(4):213-8. PubMed ID: 17012985
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection.
Marais D; Gawarecki D; Allan B; Ahmed K; Altini L; Cassim N; Gopolang F; Hoffman M; Ramjee G; Williamson AL
Antivir Ther; 2011; 16(8):1219-26. PubMed ID: 22155903
[TBL] [Abstract][Full Text] [Related]
5. The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial.
Ramjee G; van der Straten A; Chipato T; de Bruyn G; Blanchard K; Shiboski S; Cheng H; Montgomery E; Padian N;
PLoS One; 2008; 3(10):e3488. PubMed ID: 18941533
[TBL] [Abstract][Full Text] [Related]
6. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
[TBL] [Abstract][Full Text] [Related]
7. The use of the diaphragm instead of condoms in a phase III diaphragm trial.
van der Straten A; Cheng H; Moore J; Kacanek D; Blanchard K; De Bruyn G; Ramjee G; Chipato T; Montgomery ET; Padian N;
AIDS Behav; 2009 Jun; 13(3):564-72. PubMed ID: 19085099
[TBL] [Abstract][Full Text] [Related]
8. The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2.
de Bruyn G; Shiboski S; van der Straten A; Blanchard K; Chipato T; Ramjee G; Montgomery E; Padian N;
Sex Transm Infect; 2011 Jun; 87(4):301-5. PubMed ID: 21447515
[TBL] [Abstract][Full Text] [Related]
9. Predictors of adherent use of diaphragms and microbicide gel in a four-arm, randomized pilot study among female sex workers in Madagascar.
Turner AN; Van Damme K; Jamieson DJ; Khan MR; Pettifor AE; Swezey TA; Bell AJ; Newman DR; Penman-Aguilar A; Raharinivo MS; Randrianasolo B; Ramiandrisoa FN; Behets FM;
Sex Transm Dis; 2009 Apr; 36(4):249-57. PubMed ID: 19265745
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.
Barnhart KT; Rosenberg MJ; MacKay HT; Blithe DL; Higgins J; Walsh T; Wan L; Thomas M; Creinin MD; Westhoff C; Schlaff W; Archer DF; Ayers C; Kaunitz A; Das S; Moench TR
Obstet Gynecol; 2007 Sep; 110(3):577-86. PubMed ID: 17766603
[TBL] [Abstract][Full Text] [Related]
11. Impact of human immunodeficiency virus on the natural history of human papillomavirus genital infection in South African men and women.
Mbulawa ZZ; Marais DJ; Johnson LF; Coetzee D; Williamson AL
J Infect Dis; 2012 Jul; 206(1):15-27. PubMed ID: 22517913
[TBL] [Abstract][Full Text] [Related]
12. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
[TBL] [Abstract][Full Text] [Related]
13. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
[TBL] [Abstract][Full Text] [Related]
14. Diaphragm and lubricant gel acceptance, skills and patterns of use among women in an effectiveness trial in Southern Africa.
Montgomery ET; Blanchard K; Cheng H; Chipato T; de Bruyn G; Ramjee G; Padian N; van der Straten A;
Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):410-9. PubMed ID: 19929644
[TBL] [Abstract][Full Text] [Related]
15. User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa.
Sahin-Hodoglugil NN; Montgomery E; Kacanek D; Morar N; Mtetwa S; Nkala B; Philip J; Ramjee G; Cheng H; van der Straten A; The Mira Team
AIDS Care; 2011 Aug; 23(8):1026-34. PubMed ID: 21480005
[TBL] [Abstract][Full Text] [Related]
16. Prospective follow-up of 2,065 young unscreened women to study human papillomavirus incidence and clearance.
Schmeink CE; Massuger LF; Lenselink CH; Quint WG; Witte BI; Berkhof J; Melchers WJ; Bekkers RL
Int J Cancer; 2013 Jul; 133(1):172-81. PubMed ID: 23233366
[TBL] [Abstract][Full Text] [Related]
17. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Palefsky JM; Holly EA; Ralston ML; Da Costa M ; Greenblatt RM
J Infect Dis; 2001 Feb; 183(3):383-91. PubMed ID: 11133369
[TBL] [Abstract][Full Text] [Related]
19. Change in condom and other barrier method use during and after an HIV prevention trial in Zimbabwe.
van der Straten A; Cheng H; Minnis AM
J Int AIDS Soc; 2010 Oct; 13():39. PubMed ID: 20955629
[TBL] [Abstract][Full Text] [Related]
20. Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa.
Montgomery ET; Cheng H; van der Straten A; Chidanyika AC; Lince N; Blanchard K; Ramjee G; Nkala B; Padian NS;
AIDS Behav; 2010 Jun; 14(3):629-38. PubMed ID: 19757018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
